450 related articles for article (PubMed ID: 19716463)
1. Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection.
Rajabally YA; Ramlackhansingh A; Fraser M; Abbott RJ
Neurophysiol Clin; 2009 Aug; 39(3):135-8. PubMed ID: 19716463
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
3. [Guillain-Barré syndrome associated Campylobacter jejuni serogroup Penner A showing antecedent fever and abdominal pain without diarrhea].
Fukushima T; Yukawa T; Makino K; Matsubara N; Yamazaki M
No To Shinkei; 2005 Oct; 57(10):889-92. PubMed ID: 16277234
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
[TBL] [Abstract][Full Text] [Related]
5. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
[TBL] [Abstract][Full Text] [Related]
6. [A case of axonal form of Guillain-Barré syndrome associated with anti-GM1b IgG antibody following Penner 4 Campylobacter jejuni infection].
Nagayama S; Kurohara K; Matsui M; Kuroda Y; Kusunoki S
Rinsho Shinkeigaku; 1997 Jun; 37(6):506-8. PubMed ID: 9366179
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric Guillain-Barré syndrome.
Logullo F; Manicone M; Di Bella P; Provinciali L
Neurol Sci; 2006 Nov; 27(5):355-9. PubMed ID: 17122947
[TBL] [Abstract][Full Text] [Related]
8. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
[TBL] [Abstract][Full Text] [Related]
9. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
[TBL] [Abstract][Full Text] [Related]
10. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study.
Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S
Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394
[TBL] [Abstract][Full Text] [Related]
11. Axonal Guillain-Barré syndrome: concepts and controversies.
Kuwabara S; Yuki N
Lancet Neurol; 2013 Dec; 12(12):1180-8. PubMed ID: 24229616
[TBL] [Abstract][Full Text] [Related]
12. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
14. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
15. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome].
Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL
Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119
[TBL] [Abstract][Full Text] [Related]
16. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
17. [Hyperreflexia in a patient with Guillain Barre syndrome].
Badía Picazo MC; Santonja Llabata JM; Gil Gimeno R; Salvador Aliaga A; Pascual Lozano AM; Láinez Andrés JM
Rev Neurol; 2004 Apr 1-15; 38(7):697-8. PubMed ID: 15098195
[No Abstract] [Full Text] [Related]
18. [Guillain-Barré syndrome and infection].
Saida T; Hao Q; Obayashi H; Nishimura K; Ozawa K; Saida K
Rinsho Shinkeigaku; 1995 Dec; 35(12):1378-9. PubMed ID: 8752403
[No Abstract] [Full Text] [Related]
19. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Shu XM; Cai FC; Zhang XP
Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter jejuni-induced acute transverse myelitis.
Baar I; Jacobs BC; Govers N; Jorens PG; Parizel PM; Cras P
Spinal Cord; 2007 Oct; 45(10):690-4. PubMed ID: 17297497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
